IntoCell and Xcellon Biologics Announce MOU to Expand Access to Next-Generation ADC Technologies

IntoCell Inc. (KOSDAQ: 287840), a biotechnology company developing next-generation payload and linker technologies for antibody–drug conjugates (ADCs), and Xcellon Biologics, a U.S.-based contract ...
Observer

This Longevity Startup Is Bringing Anti-Aging Gene Therapy to Human Trials

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...

Researchers patent formula to block the transition from acute to chronic pain

Anyone who has experienced chronic pain knows how debilitating it can be. Just ask Daniele Piomelli, Ph.D., who has dealt ...

This new Android 16 feature will cut down the time you spend waiting for apps to update

According to Android Authority, the new “Seamless app updates” feature cuts down the time apps remain frozen, allowing users ...